Purinergic Signalling最新文献

筛选
英文 中文
Ligand-directed covalent labelling of adenosine receptors.
IF 3 4区 医学
Purinergic Signalling Pub Date : 2025-02-24 DOI: 10.1007/s11302-025-10073-y
Chloe Keduan Li, Karen Joan Gregory, Manuela Jörg
{"title":"Ligand-directed covalent labelling of adenosine receptors.","authors":"Chloe Keduan Li, Karen Joan Gregory, Manuela Jörg","doi":"10.1007/s11302-025-10073-y","DOIUrl":"https://doi.org/10.1007/s11302-025-10073-y","url":null,"abstract":"","PeriodicalId":20952,"journal":{"name":"Purinergic Signalling","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143484009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First evidence of Tityus confluens Borelli, 1899 (Buthidae) venom altering purine metabolism in rat blood cells.
IF 3 4区 医学
Purinergic Signalling Pub Date : 2025-02-24 DOI: 10.1007/s11302-025-10076-9
Romário da Silva Portilho, Igor Leal Brito, Andreza Negreli Santos, Bruna Pache Moreschi, Malson Neilson de Lucena, Jeandre Augusto Otsubo Jaques
{"title":"First evidence of Tityus confluens Borelli, 1899 (Buthidae) venom altering purine metabolism in rat blood cells.","authors":"Romário da Silva Portilho, Igor Leal Brito, Andreza Negreli Santos, Bruna Pache Moreschi, Malson Neilson de Lucena, Jeandre Augusto Otsubo Jaques","doi":"10.1007/s11302-025-10076-9","DOIUrl":"https://doi.org/10.1007/s11302-025-10076-9","url":null,"abstract":"<p><p>Purinergic signaling pathways play crucial roles in regulating hemostatic and inflammatory responses, both of which are impacted by scorpion envenomation. Scorpion venoms are complex mixtures of various toxins, such as peptides, enzymes, and nucleotides. Previous research showed that the action of scorpion toxins on the purinergic system stems from their effects on purinergic receptors. Additionally, a study identified a putative ectonucleotidase in scorpion venom. This study aimed to investigate the ability of Tityus confluens venom (10, 50, and 100 µg/mL) to metabolize adenine nucleotides and its potential effects on purinergic enzyme activity in rat platelets and lymphocytes. The effects of T. confluens venom on E-NTPDase (ATP and ADP hydrolysis), E-5'-NT (AMP hydrolysis), and E-ADA (ADO hydrolysis) activities were analyzed. The results revealed that crude venom from T. confluens exhibited ATP hydrolysis activity at all tested concentrations. In lymphocytes, ADP hydrolysis was inhibited by 100 µg/mL crude venom, whereas ADO hydrolysis was increased by all venom concentrations. In platelets, ATP hydrolysis was inhibited by 50 and 100 µg/mL crude venom, whereas AMP and ADO hydrolysis were inhibited by all concentrations. When considered collectively, the data suggested an elevation in extracellular ATP levels and a reduction in extracellular ADO. These findings are in alignment with clinical manifestations of scorpion envenomation characterized by a pro-inflammatory milieu. Furthermore, this study demonstrated the intrinsic ATPase activity of T. confluens venom and its ability to modulate E-NTPDase, E-5'-NT, and E-ADA activities in rat blood cells.</p>","PeriodicalId":20952,"journal":{"name":"Purinergic Signalling","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143483996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SCH58261 effectively prevents the reduction in excitability of striatal MSNs in mice following 20 h of sleep deprivation.
IF 3 4区 医学
Purinergic Signalling Pub Date : 2025-02-19 DOI: 10.1007/s11302-025-10072-z
Jin Peng, Xinyu Huang, Peijie Liu, Yushi Hu, Liang Kang
{"title":"SCH58261 effectively prevents the reduction in excitability of striatal MSNs in mice following 20 h of sleep deprivation.","authors":"Jin Peng, Xinyu Huang, Peijie Liu, Yushi Hu, Liang Kang","doi":"10.1007/s11302-025-10072-z","DOIUrl":"https://doi.org/10.1007/s11302-025-10072-z","url":null,"abstract":"<p><p>Adenosine, a sleep-associated neuromodulator, is crucial in various physiological and pathological processes. Previous studies have demonstrated that sleep deprivation (SD) alters striatal neuronal activity. In this study, we used in vitro electrophysiological recordings to investigate the effects of 20 h of SD on the neuronal excitability of mouse dorsal striatal medium spiny neurons (MSNs). Our findings revealed that SD resulted in altered action potential (AP) discharge properties and reduced neuronal excitability compared to the control group. Importantly, these changes were partially offset by the prophylactic injection of the A2A receptor (A2AR) antagonist SCH58261. Additionally, 20 h of SD caused a decrease in the amplitude and an increase in the interval of spontaneous excitatory postsynaptic currents (sEPSCs) compared to control. However, the prophylactic injection of the A2AR antagonism shortened the sEPSC interval, while the A1 receptor (A1R) antagonist DPCPX not only shortened the interval but also further reduced the amplitude of sEPSCs. Thus, it can be concluded that SCH58261 effectively prevents the reduction in excitability of striatal MSNs in mice following 20 h of sleep deprivation, whereas DPCPX does not.</p>","PeriodicalId":20952,"journal":{"name":"Purinergic Signalling","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143449819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A2B adenosine receptor-triggered intracellular calcium mobilization: Cell type-dependent involvement of Gi, Gq, Gs proteins and protein kinase C.
IF 3 4区 医学
Purinergic Signalling Pub Date : 2025-02-11 DOI: 10.1007/s11302-025-10070-1
Zhan-Guo Gao, Ray R Gao, Clayton K Meyer, Kenneth A Jacobson
{"title":"A<sub>2B</sub> adenosine receptor-triggered intracellular calcium mobilization: Cell type-dependent involvement of G<sub>i</sub>, G<sub>q</sub>, G<sub>s</sub> proteins and protein kinase C.","authors":"Zhan-Guo Gao, Ray R Gao, Clayton K Meyer, Kenneth A Jacobson","doi":"10.1007/s11302-025-10070-1","DOIUrl":"10.1007/s11302-025-10070-1","url":null,"abstract":"<p><p>Activation of PLCβ enzymes by G<sub>iβγ</sub> and G<sub>αq/11</sub> proteins is a common mechanism to trigger cytosolic Ca<sup>2+</sup> increase. We and others reported that G<sub>αq/11</sub> inhibitor FR900359 (FR) can inhibit both G<sub>αq</sub>- and, surprisingly, G<sub>iβγ</sub>-mediated intracellular Ca<sup>2+</sup> mobilization. Thus, the G<sub>αi</sub>-G<sub>βγ</sub>-PLCβ-Ca<sup>2+</sup> signaling axis depends entirely on the presence of active G<sub>αq</sub>, which reasonably explained FR-inhibited G<sub>iβγ</sub>-induced Ca<sup>2+</sup> release. However, the conclusion that G<sub>iβγ</sub> signaling is controlled by G<sub>αq</sub> derives mostly from HEK293 cells. Here we show that indeed in HEK293 cells both G<sub>αq/11</sub> siRNA and G<sub>αq/11</sub> inhibitors diminished Ca<sup>2+</sup> increase triggered by native G<sub>q</sub>-coupled P2Y<sub>1</sub> receptors, or by transfected G<sub>i</sub>-coupled A<sub>1</sub>- or G<sub>s</sub>-coupled A<sub>2B</sub> adenosine receptors (ARs). However, in T24 bladder cancer cells, G<sub>i</sub> inhibitor PTX, but not G<sub>αq/11</sub> inhibitors, FR, YM254890 (YM) or G<sub>q/11</sub> siRNA, inhibited Ca<sup>2+</sup> increase triggered by native A<sub>2B</sub>AR activation. Simultaneous inactivation of G<sub>i</sub> and G<sub>s</sub> further suppressed A<sub>2B</sub>AR-triggered Ca<sup>2+</sup> increase in T24 cells. The G<sub>αq/11</sub> inhibitor YM fully and partially inhibited endogenous P2Y<sub>1</sub>- and β<sub>2</sub>-adrenergic receptor-induced Ca<sup>2+</sup> increase in T24 cells, respectively. PKC activator PMA partially diminished A<sub>2B</sub>AR-triggered but completely diminished β<sub>2</sub>-adrenergic receptor-triggered Ca<sup>2+</sup> increase in T24 cells. Neither β-arrestin1 nor β-arrestin2 siRNA affected A<sub>2B</sub>AR-mediated Ca<sup>2+</sup> increase. Unlike in T24 cells, YM inhibited native A<sub>2B</sub>AR-triggered calcium mobilization in MDA-MB-231 breast cancer cells. Thus, G<sub>αq/11</sub> is vital for Ca<sup>2+</sup> increase in some cell types, but G<sub>iβγ</sub>-mediated Ca<sup>2+</sup> signaling can be Gα<sub>q/11</sub>-dependent or independent based on cell type and receptor activated. Besides G proteins, PKC also modulates cytosolic Ca<sup>2+</sup> increase depending on cell type and receptor.</p>","PeriodicalId":20952,"journal":{"name":"Purinergic Signalling","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143399825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Purinergic system in cancer stem cells. 肿瘤干细胞中的嘌呤能系统。
IF 3 4区 医学
Purinergic Signalling Pub Date : 2025-02-01 Epub Date: 2023-11-15 DOI: 10.1007/s11302-023-09976-5
J D Nuñez-Rios, H Ulrich, M Díaz-Muñoz, C Lameu, F G Vázquez-Cuevas
{"title":"Purinergic system in cancer stem cells.","authors":"J D Nuñez-Rios, H Ulrich, M Díaz-Muñoz, C Lameu, F G Vázquez-Cuevas","doi":"10.1007/s11302-023-09976-5","DOIUrl":"10.1007/s11302-023-09976-5","url":null,"abstract":"<p><p>Accumulating evidence supports the idea that cancer stem cells (CSCs) are those with the capacity to initiate tumors, generate phenotypical diversity, sustain growth, confer drug resistance, and orchestrate the spread of tumor cells. It is still controversial whether CSCs originate from normal stem cells residing in the tissue or cancer cells from the tumor bulk that have dedifferentiated to acquire stem-like characteristics. Although CSCs have been pointed out as key drivers in cancer, knowledge regarding their physiology is still blurry; thus, research focusing on CSCs is essential to designing novel and more effective therapeutics. The purinergic system has emerged as an important autocrine-paracrine messenger system with a prominent role at multiple levels of the tumor microenvironment, where it regulates cellular aspects of the tumors themselves and the stromal and immune systems. Recent findings have shown that purinergic signaling also participates in regulating the CSC phenotype. Here, we discuss updated information regarding CSCs in the purinergic system and present evidence supporting the idea that elements of the purinergic system expressed by this subpopulation of the tumor represent attractive pharmacological targets for proposing innovative anti-cancer therapies.</p>","PeriodicalId":20952,"journal":{"name":"Purinergic Signalling","volume":" ","pages":"23-38"},"PeriodicalIF":3.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11904000/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"107592133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adventures in translation.
IF 3 4区 医学
Purinergic Signalling Pub Date : 2025-01-24 DOI: 10.1007/s11302-025-10069-8
Bruce Cronstein, Siddhesh R Angle
{"title":"Adventures in translation.","authors":"Bruce Cronstein, Siddhesh R Angle","doi":"10.1007/s11302-025-10069-8","DOIUrl":"10.1007/s11302-025-10069-8","url":null,"abstract":"","PeriodicalId":20952,"journal":{"name":"Purinergic Signalling","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143029422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Purinergic signaling in health: special issue of purines 2022 in Brazil. 健康中的嘌呤能信号:2022年巴西嘌呤特刊。
IF 3 4区 医学
Purinergic Signalling Pub Date : 2025-01-21 DOI: 10.1007/s11302-025-10067-w
Henning Ulrich, Carla I Tasca, Claudiana Lameu
{"title":"Purinergic signaling in health: special issue of purines 2022 in Brazil.","authors":"Henning Ulrich, Carla I Tasca, Claudiana Lameu","doi":"10.1007/s11302-025-10067-w","DOIUrl":"https://doi.org/10.1007/s11302-025-10067-w","url":null,"abstract":"","PeriodicalId":20952,"journal":{"name":"Purinergic Signalling","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143010624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracellular ATP regulates phagocytic activity, mitochondrial respiration, and cytokine secretion of human astrocytic cells. 细胞外ATP调节人类星形细胞的吞噬活性、线粒体呼吸和细胞因子分泌。
IF 3 4区 医学
Purinergic Signalling Pub Date : 2025-01-21 DOI: 10.1007/s11302-025-10066-x
Sijie Shirley Yang, Noah A H Brooks, Dylan E Da Silva, Julien Gibon, Hashim Islam, Andis Klegeris
{"title":"Extracellular ATP regulates phagocytic activity, mitochondrial respiration, and cytokine secretion of human astrocytic cells.","authors":"Sijie Shirley Yang, Noah A H Brooks, Dylan E Da Silva, Julien Gibon, Hashim Islam, Andis Klegeris","doi":"10.1007/s11302-025-10066-x","DOIUrl":"https://doi.org/10.1007/s11302-025-10066-x","url":null,"abstract":"<p><p>The two main glial cell types of the central nervous system (CNS), astrocytes and microglia, are responsible for neuroimmune homeostasis. Recent evidence indicates astrocytes can participate in removal of pathological structures by becoming phagocytic under conditions of neurodegenerative disease when microglia, the professional phagocytes, are impaired. We hypothesized that adenosine triphosphate (ATP), which acts as damage-associated molecular pattern (DAMP), when released at high concentrations into extracellular space, upregulates phagocytic activity of human astrocytes. This study is the first to measure changes in phagocytic activity and mitochondrial respiration of human astrocytic cells in response to extracellular ATP. We demonstrate that ATP-induced phagocytic activity of U118 MG astrocytic cells is accompanied by upregulated mitochondrial oxidative phosphorylation, which likely supports this energy-dependent process. Application of a selective antagonist A438079 provides evidence identifying astrocytic purinergic P2X7 receptor (P2X7R) as the potential regulator of their phagocytic function. We also report a rapid ATP-induced increase in intracellular calcium ([Ca<sup>2+</sup>]<sub>i</sub>), which could serve as regulator of both the phagocytic activity and mitochondrial metabolism, but this hypothesis will need to be tested in future studies. Since ATP upregulates interleukin (IL)-8 secretion by astrocytes but has no effect on their cytotoxicity towards neuronal cells, we conclude that extracellular ATP affects only specific functions of astrocytes. The selectivity of P2X7R-dependent regulation of astrocyte functions by extracellular ATP could allow targeting this receptor-ligand interaction to upregulate their phagocytic function. This could have beneficial outcomes in neurodegenerative disorders, such as Alzheimer's disease, that are characterized by reactive astrocytes and defective phagocytic processes.</p>","PeriodicalId":20952,"journal":{"name":"Purinergic Signalling","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143010617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P2Y1R-IGFBP2 signaling: new contributor to astrocyte-neuron communication. P2Y1R-IGFBP2信号:星形细胞-神经元通讯的新贡献者。
IF 3 4区 医学
Purinergic Signalling Pub Date : 2025-01-18 DOI: 10.1007/s11302-025-10068-9
Dan Huang, Yong Tang
{"title":"P2Y<sub>1</sub>R-IGFBP2 signaling: new contributor to astrocyte-neuron communication.","authors":"Dan Huang, Yong Tang","doi":"10.1007/s11302-025-10068-9","DOIUrl":"https://doi.org/10.1007/s11302-025-10068-9","url":null,"abstract":"<p><p>In a recent article published in Nature Communications (Shigetomi et al Nat Commun 15(1):6525, 2024), Shigetomi et al. identified that upregulated astrocytic purinergic P2Y<sub>1</sub> receptors (P2Y<sub>1</sub>R), acting via the downstream molecule, insulin-like growth factor binding protein 2 (IGFBP2), play a crucial role in neuronal hyperexcitability. In epilepsy and stroke models, P2Y<sub>1</sub>R-IGFBP2 signaling was found to mediate astrocyte-driven neuronal hyperexcitability and so is a new contributor to astrocyte-neuron communication. Thus, IGFBP2 could be an alternative target for treating the effects of upregulated P2Y<sub>1</sub>R activity in reactive astrocytes in neurological diseases.</p>","PeriodicalId":20952,"journal":{"name":"Purinergic Signalling","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143010621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Purinergic regulation of pulmonary vascular tone. 嘌呤能调节肺血管张力。
IF 3 4区 医学
Purinergic Signalling Pub Date : 2024-12-01 Epub Date: 2024-05-07 DOI: 10.1007/s11302-024-10010-5
Marco Alveal, Andrea Méndez, Aline García, Mauricio Henríquez
{"title":"Purinergic regulation of pulmonary vascular tone.","authors":"Marco Alveal, Andrea Méndez, Aline García, Mauricio Henríquez","doi":"10.1007/s11302-024-10010-5","DOIUrl":"10.1007/s11302-024-10010-5","url":null,"abstract":"<p><p>Purinergic signaling is a crucial determinant in the regulation of pulmonary vascular physiology and presents a promising avenue for addressing lung diseases. This intricate signaling system encompasses two primary receptor classes: P1 and P2 receptors. P1 receptors selectively bind adenosine, while P2 receptors exhibit an affinity for ATP, ADP, UTP, and UDP. Functionally, P1 receptors are associated with vasodilation, while P2 receptors mediate vasoconstriction, particularly in basally relaxed vessels, through modulation of intracellular Ca<sup>2+</sup> levels. The P2X subtype receptors facilitate extracellular Ca<sup>2+</sup> influx, while the P2Y subtype receptors are linked to endoplasmic reticulum Ca<sup>2+</sup> release. Notably, the primary receptor responsible for ATP-induced vasoconstriction is P2X1, with α,β-meATP and UDP being identified as potent vasoconstrictor agonists. Interestingly, ATP has been shown to induce endothelium-dependent vasodilation in pre-constricted vessels, associated with nitric oxide (NO) release. In the context of P1 receptors, adenosine stimulation of pulmonary vessels has been unequivocally demonstrated to induce vasodilation, with a clear dependency on the A<sub>2B</sub> receptor, as evidenced in studies involving guinea pigs and rats. Importantly, evidence strongly suggests that this vasodilation occurs independently of endothelium-mediated mechanisms. Furthermore, studies have revealed variations in the expression of purinergic receptors across different vessel sizes, with reports indicating notably higher expression of P2Y<sub>1</sub>, P2Y<sub>2</sub>, and P2Y<sub>4</sub> receptors in small pulmonary arteries. While the existing evidence in this area is still emerging, it underscores the urgent need for a comprehensive examination of the specific characteristics of purinergic signaling in the regulation of pulmonary vascular tone, particularly focusing on the disparities observed across different intrapulmonary vessel sizes. Consequently, this review aims to meticulously explore the current evidence regarding the role of purinergic signaling in pulmonary vascular tone regulation, with a specific emphasis on the variations observed in intrapulmonary vessel sizes. This endeavor is critical, as purinergic signaling holds substantial promise in the modulation of vascular tone and in the proactive prevention and treatment of pulmonary vascular diseases.</p>","PeriodicalId":20952,"journal":{"name":"Purinergic Signalling","volume":" ","pages":"595-606"},"PeriodicalIF":3.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554604/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140857415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信